Evidence map›Paper›PMID 37658825›Full record

ArticleBrain : a journal of neurology2024

Impaired glucose utilization in the brain of patients with delirium following hip fracture.

Irit Titlestad, Leiv Otto Watne, Gideon A Caplan, Adrian McCann, Per Magne Ueland, Bjørn Erik Neerland, Marius Myrstad, Nathalie Bodd Halaas, Christian Thomas Pollmann, Kristi Henjum and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Cerebral metabolic covariance in delirium: pattern response to symptomatic changes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Irit TitlestadDepartment of Clinical Medicine, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0001-9608-7654
Leiv Otto WatneOslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Gideon A CaplanDepartment of Geriatric Medicine, Prince of Wales Hospital, 2031 Sydney, Australia.
Adrian McCannBevital AS, 5021 Bergen, Norway.ORCID 0000-0002-5728-5321
Per Magne UelandBevital AS, 5021 Bergen, Norway.
Bjørn Erik NeerlandOslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Marius MyrstadDepartment of Internal Medicine, Bærum Hospital Vestre Viken Hospital Trust, 1346 Gjettum, Norway.
Nathalie Bodd HalaasOslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Christian Thomas PollmannDepartment of Orthopedic Surgery, Akershus University Hospital, 1478 Lørenskog, Norway.
Kristi HenjumOslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, 0424 Oslo, Norway.ORCID 0000-0001-9147-7282
Anette Hylen RanhoffDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway.
Lene B SolbergDivision of Orthopaedic Surgery, Oslo University Hospital, 0424 Oslo, Norway.
Wender FigvedInstitute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
Colm CunninghamSchool of Biochemistry & Immunology, Trinity Biomedical Sciences Institute and Trinity College Institute of Neuroscience, Trinity College Dublin, D02 R590 Dublin, Ireland.
Lasse M GiilNeuro-SysMed, Department of Internal Medicine, Haraldsplass Deaconess Hospital, 5009 Bergen, Norway.
Oslo University Hospital · NOBevital (Norway) · NOAkershus University Hospital · NODiakonhjemmet Hospital · NOTrinity College Dublin · IEUniversity of Bergen · NOUniversity of Oslo · NOUNSW Sydney · AUVestre Viken Hospital Trust · NO

Funding

Neuro-SysMedNorwegian Health AssociationNorwegian Research CouncilSouth-Eastern Norway Regional Health Authorities #2017095University of Bergen
6 · The paper itself

Abstract

Alterations in brain energy metabolism have long been proposed as one of several neurobiological processes contributing to delirium. This is supported by previous findings of altered CSF lactate and neuron-specific enolase concentrations and decreased glucose uptake on brain-PET in patients with delirium. Despite this, there are limited data on metabolic alterations found in CSF samples, and targeted metabolic profiling of CSF metabolites involved in energy metabolism has not been performed. The aim of the study was to investigate whether metabolites related to energy metabolism in the serum and CSF of patients with hip fracture are associated with delirium. The study cohort included 406 patients with a mean age of 81 years (standard deviation 10 years), acutely admitted to hospital for surgical repair of a hip fracture. Delirium was assessed daily until the fifth postoperative day. CSF was collected from all 406 participants at the onset of spinal anaesthesia, and serum samples were drawn concurrently from 213 participants. Glucose and lactate in CSF were measured using amperometry, whereas plasma glucose was measured in the clinical laboratory using enzymatic photometry. Serum and CSF concentrations of the branched-chain amino acids, 3-hydroxyisobutyric acid, acetoacetate and β-hydroxybutyrate were measured using gas chromatography-tandem mass spectrometry (GC-MS/MS). In total, 224 (55%) patients developed delirium pre- or postoperatively. Ketone body concentrations (acetoacetate, β-hydroxybutyrate) and branched-chain amino acids were significantly elevated in the CSF but not in serum among patients with delirium, despite no group differences in glucose concentrations. The level of 3-hydroxyisobutyric acid was significantly elevated in both CSF and serum. An elevation of CSF lactate during delirium was explained by age and comorbidity. Our data suggest that altered glucose utilization and a shift to ketone body metabolism occurs in the brain during delirium.

Indexed as

DeliriumHip Fractures3-Hydroxybutyric AcidAcetoacetatesAged, 80 and overAmino Acids, Branched-ChainBrainGlucoseHumansHydroxybutyratesLactatesTandem Mass Spectrometry3-Hydroxybutyric Acid3-hydroxyisobutyric acidAcetoacetatesacetoacetic acidAmino Acids, Branched-ChainGlucoseHydroxybutyratesLactates3-hydroxyisobutyrateacetoacetatebranched-chain amino acidslactateβ-hydroxybutyrate

Identifiers

PMID37658825
PMCPMC10766236
OpenAlexW4386390737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.